Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
39.80
+0.02 (0.05%)
Jun 27, 2025, 4:00 PM - Market closed
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
$670,957
Profits / Employee
-$428,468
Market Cap
6.33B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IONS News
- 3 days ago - Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results - Business Wire
- 16 days ago - Ionis announces Dr. Richard Geary, chief development officer, to retire; Dr. Holly Kordasiewicz to assume role in January 2026 - Business Wire
- 17 days ago - First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome - Business Wire
- 5 weeks ago - Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides - Business Wire
- 7 weeks ago - Ionis to host 2025 virtual Annual Meeting of Stockholders - Business Wire
- 2 months ago - Ionis Pharmaceuticals, Inc. (IONS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ionis Pharmaceuticals Narrows Q1 Loss, Lifts Revenue Forecast While Drug Sales Surge - Benzinga
- 2 months ago - Ionis reports first quarter 2025 financial results - Business Wire